Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-02-24 Sale | 2026-02-24 8:53 pm | Caribou Biosciences Inc. | CRBU | Albertson Tina M. Chief Medical Officer | 1,066 | $1.96 | $2,089 | 316,023 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-02-20 Option Award | 2026-02-24 8:53 pm | N/A 2036-02-19 | Caribou Biosciences Inc. | CRBU | Albertson Tina M. Chief Medical Officer | 302,500 | $0 | 316,023 (Direct) | View |
| 2025-02-20 Option Award | 2025-02-21 8:20 pm | N/A 2035-02-19 | Caribou Biosciences Inc. | CRBU | Albertson Tina M. Chief Medical Officer | 80,726 | $0 | 80,726 (Direct) | View |
| 2024-08-19 Option Award | 2024-08-20 4:07 pm | N/A 2034-08-18 | Caribou Biosciences Inc. | CRBU | Albertson Tina M. Chief Medical Officer | 300,000 | $0 | 300,000 (Direct) | View |
| 2023-02-24 Option Award | 2023-02-28 6:19 pm | N/A 2033-02-23 | Lyell Immunopharma Inc. | LYEL | Albertson Tina M. Chief Medical Officer | 700,000 | $0 | 704,049 (Direct) | View |
Ownership | 2022-03-29 5:05 pm | N/A 2030-08-09 | Lyell Immunopharma Inc. | LYEL | Albertson Tina M. Chief Medical Officer | 0 | $0 | 1,500,000 (Direct) | View |